Home / Pharma Healthcare / Global Travel Vaccines Market Research Report 2018

Global Travel Vaccines Market Research Report 2018

  • Id : RNR-1906
  • Category : Pharma Healthcare
  • Publish Date : 2018
  • Pages : 156
  • Format : PDF
License Type

This study researches the market size of Travel Vaccines, presents the global Travel Vaccines sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Travel Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Travel Vaccines for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Vaccines are a combination of killed microorganisms, living attenuated organisms or living fully virulent organisms that are monitored for artificially increasing or creating immunity for any particular disease. The branch of medicine that deals with the prevention and management of health problems of international travellers is called Emporiatrics. Travel vaccine is the first step towards smart and healthy travel. Nowadays along with the passport, travel vaccine shots are a must have before a person embarks on international travel. Travel vaccines provide immunisation by reducing the risk of getting sick while travelling abroad. Tourists traveling to South America and central countries of Africa should get vaccinated for Yellow Fever. Likewise, different countries have different diseases existing or prevailing within the region. Travel vaccines are recommended by health organisations especially to tourists who travel to developing or endemic countries. DUKORAL is an example of a travel vaccine that protects tourists from Diarrhea and Cholera. These are the common diseases caused by intake of contaminated food and water while travelling. Travel vaccine shot recommendations vary from person to person depending on gender, age and medical history of the tourist.

As the world continues to move toward globalization, the international travels is expected to keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan.

The Americas was the highest revenue contributing region in the market during 2017 and is expected to continue to lead the market in the coming years. The US was one of the highest revenue contributor in the region, capturing a significant portion of the global market. The increasing demand for vaccines that cater to the unmet medical needs provides an opportunity for vendors to develop new safe and efficient molecules, which will aid in the growth of this market in the region.

In 2018, the global Travel Vaccines market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Travel Vaccines.

This report includes the following manufacturers; we can also add the other companies as you want.








    Takeda Pharmaceutical

    Valeant Pharmaceuticals

    SK Chemicals

    Hualan Biological Engineering

    Serum Institute of India

Market Segment by Product Type

    Meningococcal Vaccines

    Hepatitis B Vaccines

    Hepatitis A Vaccines


Market Segment by Application

    Domestic Travel

    Outbound Travel

Market size split by Region

    North America

        United States







        South Korea













    Central & South America


        Rest of Central & South America

    Middle East & Africa

        GCC Countries


        South Africa

The study objectives are:

    To analyze and research the global Travel Vaccines status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

    To present the key Travel Vaccines manufacturers, capacity, production, revenue, market share, and recent development for key players.

    To split the breakdown data by regions, type, companies and applications.

    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

    To identify significant trends, drivers, influence factors in global and regions.

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Travel Vaccines are as follows:

    History Year: 2013-2018

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025